Search results
Results from the WOW.Com Content Network
The United States Food and Drugs Administration is warning pet owners about a common medication given to pets to treat arthritis. The F.D.A. now says that the drug Librela may be associated with ...
A study of 66 dogs with Cushing's found 91% of dogs to have either polyuria or polydipsia, 79% to have polyphagia, and 77% to have alopecia. [4] Signs of ectopic adrenocorticotropic hormone secretion that accompany the rapidly progressing physical changes are high plasma levels of adrenocorticotropic hormones and cortisol alongside hypokalaemia ...
Worms and other internal parasites can be treated easily but are some of the most common problems seen in dogs. Some of the internal parasites that cause diarrhea and loose stools in puppies ...
It is a congenital heart disease in dogs. There usually are no signs in dogs except for a heart murmur. However, a large defect can result in heart failure or in pulmonary hypertension leading to a right-to-left shunt. [49] Atrial septal defect* is a hole in the division between the heart atria (upper chambers of the heart). It is an uncommon ...
Skin conditions in dogs are very common, so it's important to recognize the symptoms and understand the factors that cause them. Dr. Rebecca MacMillan, a vet with over 15 years of experience, says ...
[15] [16] It may also hide the early symptoms of certain forms of prostate cancer. [14] Finasteride was patented in 1984 and approved for medical use in 1992. [17] It is available as a generic medication. [18] In 2022, it was the 73rd most commonly prescribed medication in the United States, with more than 9 million prescriptions. [19] [20]
Dogs with the condition have a poor life expectancy and are often euthanised after diagnosis. [17] Clinical signs include: facial erythema, crusting and scaling, [18] skin lesions, lameness, ulcers, and disfiguration: it progresses to joint pain and azoospermia in males and disruption of the oestrous cycle in females. [17]
More than 3,600 cases of debilitating dog health problems caused by the medication were reported between January 2023 and March 2024, the FDA said in the cautionary letter, published Monday.